GUANZE MEDICAL (02427) appoints Jiang Zeman as executive director, chairman of the board and chief executive officer.
GUANZE MEDICAL (02427) announced that Mr. Guo Zhenyu has resigned from the position of executive director of the company with effect from July 1, 2026; and Ms. Meng Cathy has resigned from the position of non-executive director and member of the Nomination Committee. Ms. Jiang Zeman has been appointed as an executive director, Chairman of the Nomination Committee, and member of the Remuneration Committee of the board, and Ms. Tan Jingying has been appointed as an executive director.
GUANZE MEDICAL (02427) announced that Mr. Guo Zhenyu has resigned from his position as an executive director of the company, effective July 1, 2026. Ms. Meng Cathy has also resigned from her positions as a non-executive director and a member of the Nomination Committee. Ms. Jiang Zeman has been appointed as an executive director, Chairperson of the Nomination Committee, and a member of the Remuneration Committee. Ms. Qin Jingying has been appointed as an executive director.
Effective July 1, 2026, Ms. Jiang Zeman has been appointed as the CEO and Chairperson of the Board of Directors of the company, as well as the authorized representative. Mr. Meng Xianzhen will no longer serve as the CEO and Chairperson of the Board of Directors or the authorized representative, but will continue to serve as an executive director.
Related Articles

COSCO SHIPPING Development(02866) plans to invest 8.656 billion yuan to acquire a total of 24 vessels.

REALWAY CAPITAL(01835): Change of controlling shareholder, offering a cash offer of approximately 39.39% discount and will resume trading on July 2nd.

HUNLICAR GROUP (03638) announced its annual performance, with a net profit attributable to shareholders of HK$28.166 million.
COSCO SHIPPING Development(02866) plans to invest 8.656 billion yuan to acquire a total of 24 vessels.

REALWAY CAPITAL(01835): Change of controlling shareholder, offering a cash offer of approximately 39.39% discount and will resume trading on July 2nd.

HUNLICAR GROUP (03638) announced its annual performance, with a net profit attributable to shareholders of HK$28.166 million.

RECOMMEND





